Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis

Annals of the American Thoracic Society

Volumn 10, Issue 2, 2013, Pages 81-89

  Singanayagam, Aran ^a   Schembri, Stuart ^b   Chalmers, James D ^b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b NINEWELLS HOSPITAL   (United Kingdom)

Author keywords

Chronic obstructive pulmonary disease; Exacerbation; Mortality; Prognosis

Indexed keywords

UREA;

ACIDEMIA; AGE DISTRIBUTION; ANEMIA; AREA UNDER THE CURVE; BODY MASS; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; COHORT ANALYSIS; CONFUSION; COR PULMONALE; DEPRESSION; DIABETES MELLITUS; DISEASE EXACERBATION; FORCED EXPIRATORY VOLUME; GLASGOW COMA SCALE; HEART FAILURE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; HYPOTENSION; INTENSIVE CARE UNIT; ISCHEMIC HEART DISEASE; LONG TERM CARE; META ANALYSIS; MORTALITY; OXYGEN THERAPY; PERIPHERAL EDEMA; PH; PREDICTOR VARIABLE; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDY; PUBLISHING; QUALITY CONTROL; QUALITY OF LIFE; REVIEW; SEX DIFFERENCE; SYSTEMATIC REVIEW; TACHYCARDIA; TACHYPNEA;

ADULT; CAUSE OF DEATH; HOSPITAL MORTALITY; HUMANS; INPATIENTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECURRENCE; RESPIRATORY CARE UNITS; RISK FACTORS; WORLD HEALTH;

EID: 84880856547     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201208-043OC     Document Type: Review

References (65)

1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349:1498-1504.
2. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (updated 2010). Available from http://www.goldcopd.org/uploads/users/ files/GOLDReport-April112011.pdf
3. Connors AF Jr, Dawson NV, Thomas C, Harrell FE Jr, Desbiens N, Fulkerson WJ, Kussin P, Bellamy P, Goldman L, Knaus WA; SUPPORT Investigators. Outcomes following acute exacerbation of severe chronic obstructive lung disease: Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Am J Respir Crit Care Med 1996;154:959-967.
4. Groenewegen KH, Schols AM, Wouters EF. Mortality and mortalityrelated factors after hospitalization for acute exacerbation of COPD. Chest 2003;124:459-467.
5. Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA, Kapoor WN. Prognosis and outcomes of patients with communityacquired pneumonia: a meta analysis. JAMA 1996;275:134-141.
6. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN. A prediction rule to identify lowrisk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-250.
7. Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, Lewis SA, Macfarlane JT. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58:377-382.
8. Singanayagam A, Chalmers JD, Hill AT. Severity assessment in community-acquired pneumonia: a review. QJM 2009;102:379-388.
9. Chalmers JD, Singanayagam A, Akram AR, Mandal P, Short PM, Choudhury G, Wood V, Hill AT. Severity assessment tools for predicting mortality in hospitalised patients with communityacquired pneumonia: systematic review and meta-analysis. Thorax 2010;65:878-883.
10. Chalmers JD, Singanayagam A, Akram AR, Choudhury G, Mandal P, Hill AT. Safety and efficacy of CURB65-guided antibiotic therapy in community-acquired pneumonia. J Antimicrob Chemother 2011;66: 416-423.
11. National Institute for Health and Clinical Excellence (NICE). NICE clinical guideline 101: chronic obstructive pulmonary disease [Accessed January 8, 2012]. Available from http://www.nice.org.uk/nicemedia/live/13029/49397/ 49397.pdf
12. American Thoracic Society, European Respiratory Society. Standards for the diagnosis and management of patients with COPD [Accessed January 8, 2012]. Available from http://www.thoracic.org/clinical/copd-guidelines/resources/ copddoc.pdf
13. Chang CL, Sullivan GD, Karalus NC, Mills GD, McLachlan JD, Hancox RJ. Predicting early mortality in acute exacerbation of chronic obstructive pulmonary disease using the CURB65 score. Respirology 2011;16:146-151.
14. Steer J, Norman EM, Afolabi OA, Gibson GJ, Bourke SC. Dyspnoea severity and pneumonia as predictors of in-hospital mortality and early readmission in acute exacerbations of COPD. Thorax 2012;67:117-121.
15. Tabak YP, Sun X, Johannes RS, Gupta V, Shorr AF. Mortality and need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: development and validation of a simple risk score. Arch Intern Med 2009;169:1595-1602.
16. Shorr AF, Sun X, Johannes RS, Yaitanes A, Tabak YP. Validation of a novel risk score for severity of illness in acute exacerbations of COPD. Chest 2011;140:1177-1183.
17. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology. JAMA 2000;283:2008-2012.
18. Hayden JA, Cote P, Bombadier C. Evaluation of the quality of prognostic studies in systematic reviews. Ann Intern Med 2006;144:427-437.
19. Roberts CM, Lowe D, Bucknall CE, Ryland I, Kelly Y, earson MG. Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease. Thorax 2002;57:137-141.
20. Mortensen EM, Copeland LA, Pugh MJ, Restrepo MI, de Molina RM, Nakashima B, Anzueto A. Impact of statins and ACE inhibitors on mortality after COPD exacerbations. Respir Res 2009;10:45.
21. De La Iglesia F, Diaz JL, Pita S, Nicolá s R, Ramos V, Pellicer C, Diz-Lois F. Peak expiratory flow rate as predictor of inpatient death in patients with chronic obstructive pulmonary disease. South Med J 2005;98: 266-272.
22. Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status and quality of life. Arch Intern Med 2007;167:60-67.
23. Dransfield MT, Rowe SM, Johnson JE, Bailey WC, Gerald LB. Use of beta blockers and the risk of death in hospitalized patients with acute exacerbations of COPD. Thorax 2008;63:301-305.
24. Bustamante Fermosel A, De Miguel-Yanes JM, Duffort-Falcó M, Muñoz J. Mortality-related factors after hospitalization for acute exacerbation of chronic obstructive pulmonary disease: the burden of clinical features. Am J Emerg Med 2007;25:515-522.
25. Onadeko BO, Khadadah M, Abdella N, Mukhtar M, Mourou M, Qurtom M, Samad M, Al-Shayeb A. Prognostic factors in the management of exacerbation of chronic obstructive pulmonary disease in Kuwait. Med Princ Pract 2005;14:35-40.
26. Patil SP, Krishnan JA, Lechtzin N, Diette GB. In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch Intern Med 2003;163:1180-1186.
27. Fuso L, Antonelli Incalzi R, Pistelli R, Muzzolon R, Valente S, Pagliari G, Gliozzi F, Ciappi G. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. Am J Med 1995;98:272-277.
28. Roche N, Zureik M, Soussan D, Neukirch F, Perrotin D; Urgence BPCO (COPD Emergency) Scientific Committee. Predictors of outcomes in COPD exacerbation cases presenting to the emergency department. Eur Respir J 2008;32:953-961.
29. Connolly MJ, Lowe D, Anstey K, Hosker HS, Pearson MG, Roberts CM; British Thoracic Society and the Royal College of Physicians Clinical Effectiveness Evaluation Unit (CEEu). Admissions to hospital with exacerbations of chronic obstructive pulmonary disease: effect of age related factors and service organization. Thorax 2006;61: 843-848.
30. Warren PM, Flenley DC, Millar JS, Avery A. Respiratory failure revisited: acute exacerbations of chronic bronchitis between 1961-68 and 1970-76. Lancet 1980;1:467-470.
31. Martins CS, Rodigues MJO, Miranda VP, Nunes JP. Prognostic value of cardiac troponin I in patients with COPD acute exacerbation. Neth J Med 2009;67:341-349.
32. Gunen H, Hacievliyagil SS, Kosar F, Mutlu LC, Gulbas G, Pehlivan E, Sahin I, Kizkin O. Factors affecting survival of hospitalized patients with COPD. Eur Respir J 2005;26:234-241.
33. Steer J, Gibson J, Bourke SC. The DECAF score: predicting hospital mortality exacerbations of chronic obstructive pulmonary disease. Thorax 2012;67:970-976.
34. Soyseth V, Brekke PH, Smith P, Omland T. Statin use is associated with reduced mortality in COPD. Eur Respir J 2007;29:279-283.
35. Almagro P, Calbo E, Ochos de Echaguen A, Barreiro B, Quintana S, Heredia JL, Garau J. Mortality after hospitalization for COPD. Chest 2002;121:1441-1448.
36. Gudmundsson G, Gislason T, Lindberg E, Hallin R, Ulrik CS, Brøndum E, Nieminen MM, Aine T, Bakke P, Janson C. Mortality in COPD patients discharged from hospital: the role of treatment and comorbidity. Respir Res 2006;7:109.
37. Hallin R, Gudmundsson G, Ulrik CS, Nieminen MM, Gislason T, Lindberg E, Brøndum E, Aine T, Bakke P, Janson C. Nutritional status and long-term mortality in hospitalized patients with chronic obstructive pulmonary disease (COPD). Respir Med 2007;101: 1954-1960.
38. Ranieri P, Bianchetti A, Margiotta A, Virgillo A, Clini EM, Trabucchi M. Predictors of 6-month mortality in elderly patients with mild chronic obstructive pulmonary disease discharged from a medical ward after acute nonacidotic exacerbation. J Am Geriatr Soc 2008; 56:909-913.
39. Yohannes AM, Balldwin RC, Connolly MJ. Predictors of 1 year mortality in patients discharged from hospital following acute exacerbation of chronic obstructive pulmonary disease. Age Ageing 2005;34:491-496.
40. Martinez Rivera C, Portillo K, Munoz-Ferrer A, Mart'inez-Ortiz ML, Molins E, Serra P, Ruiz-Manzano J, Morera J. Anaemia is a mortality predictor in hospitalized patients for COPD exacerbation. COPD 2012;9:243-250.
41. Ai Ping C, Lee KH, Lim TK. In-hospital and 5-year mortality of patients treated in the ICU for acute exacerbation of COPD: a retrospective study. Chest 2005;128:518-524.
42. Baillard C, Boussarsar M, Fosse JP, Girou E, Le Toumelin P, Cracco C, Jaber S, Cohen Y, Brochard L. Cardiac troponin I in patients with severe exacerbation of chronic obstructive pulmonary disease. Intensive Care Med 2003;29:584-589.
43. Berkius J, Nolin T, Mardh C, Karlström G, Walther SM; Swedish Intensive Care Registry. Characteristics and long-term outcome of acute exacerbations in chronic obstructive pulmonary disease: an analysis of cases in the Swedish Intensive Care. Acta Anaesthiol Scand 2008;52:759-765.
44. Liu H, Zhang TT, Ye J. Analysis of risk factors for hospital mortality in patients with chronic obstructive pulmonary disease requiring invasive mechanical ventilation. Chin Med J (Engl) 2007;120:287-293.
45. Nevins ML, Epstein SK. Predictors of outcome for patients with COPD requiring invasive mechanical ventilation. Chest 2001;119:1840-1849.
46. Rammaert B, Verdier N, Cavestri B, Nseir S. Procalcitonin as a prognostic factor in severe acute exacerbation of chronic obstructive pulmonary disease. Respirology 2009;14:969-974.
47. Rivera-Fernandez R, Navarrete-Navarro P, Fernandez-Mondejar E, Rodriguez-Elvira M, Guerrero-Ló pez F, Vá zquez-Mata G; Project for the Epidemiological Analysis of Critical Care Patients (PAEEC) Group. Six year mortality and quality of life in critically ill patients with chronic obstructive pulmonary disease. Crit Care Med 2006;34:2317-2324.
48. Ucgun I, Metinas M, Moral H, Alatas F, Yildirim H, Erginel S. Predictors of hospital outcome and intubation in COPD patients admitted to the respiratory ICU for acute hypercapnic respiratory failure. Respir Med 2006;100:66-74.
49. Raurich JM, Perez J, Ibanez J, Roig S, Batle S. In-hospital and 2-year survival of patients treated with mechanical ventilation for acute exacerbation of COPD. Arch Bronconeumol 2004;40:295-300.
50. Khilnani GC, Banga A, Sharma SK. Predictors of mortality of patients with acute respiratory failure secondary to chronic obstructive pulmonary disease admitted to an intensive care unit: a one year study. BMC Pulm Med 2004;4:12.
51. Hill AT, Hopkinson RB, Stableforth DE. Ventilation in a Birmingham intensive care unit 1993-1995: outcome for patients with chronic obstructive pulmonary disease. Respir Med 1998;92:156-161.
52. Yang S, Tan KL, Devanand A, Fook-Chong S, Eng P. Acute exacerbation of COPD requiring admission to intensive care unit. Respirology 2004;9:543-549.
53. Edwards L, Perrin K, Wijesinghe M, Weatherall M, Beasley R, Travers J. The value of the CRB65 score to predict mortality in exacerbations of COPD requiring hospital admission. Respirology 2011;16:625-629.
54. Ruiz Gonzalez A, Lacasta D, Ibarz M, Mart'inez-Alonso M, Falguera M, Porcel JM. C-reactive protein and other predictors of poor outcome in patients hospitalized with exacerbations of chronic obstructive pulmonary disease. Respirology 2008;13:1028-1033.
55. Wildman MJ, Sanderson C, Groves J, Reeves BC, Ayres J, Harrison D, Young D, Rowan K. Predicting mortality for patients with exacerbations of COPD and asthma in the COPD and Asthma Outcome Study (CAOS). QJM 2009;102:389-399.
56. Reilly BM, Evans AT. Translating clinical research into clinical practice: impact of using prediction rules to make decisions. Ann Intern Med 2006;144:201-209.
57. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13: 818-829.
58. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG; Working Group on Sepsis-related Problems of the European Society of Intensive Care Medicine. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996;22:707-710.
59. Nussbaumer-Ochsner T, Rabe KF. Systemic manifestations of COPD. Chest 2011;139:165-173.
60. Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1791-1797.
61. Donaldson GC, Hurst JR, Smith CJ, Hubbard RB, Wedzicha JA. Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest 2010;137:1091-1097.
62. Stone IS, Barnes NC, Petersen SE. Chronic obstructive pulmonary disease: a modifiable risk factor for cardiovascular disease. Heart 2012;98:1055-1062.
63. Short PM, Lipworth SI, Elder DH, Schembri S, Lipworth BJ. Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study. BMJ 2011;342:d2549.
64. Mancini GB, Etminan M, Zhang B. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. J Am Coll Cardiol 2006;47:2554-2560.
65. McGhan R, Radcliff T, Fish R, Sutherland ER, Welsh C, Make B. Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest 2007;132:1748-1755.